Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Type of Cardioplegia and Cardiometabolic Impact - a Prospective Randomized Trial in Patients Undergoing CABG

NCT07386990 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT07386990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07386990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Type of Cardioplegia and Cardiometabolic Impact - a Prospective Randomized Trial in Patients Undergoing CABG
Lead sponsor
Region Skane
Phase
Phase 4
Overall status
Completed
Start date
June 15, 2021
Completion date
April 29, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardioplegia, cardiopulmonary bypass, coronary artery bypass graft (cabg), perioperative myocardial injury